Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02891941 · ClinicalTrials.gov registry record
Neuroimaging & Plasma Markers for Predicting Outcomes After Mild Traumatic Brain Injury
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 10
- Enrollment target
NCT02891941: Clinical Trial study, sponsored by Johns Hopkins University.
NCT02891941 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02891941 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This exploratory study aims to identify the most promising biomarkers that alone or in combination might predict development of mood disorders \[i.e., major depression (MD\], cognitive disorders \[i.e., executive function deficits (EFD)\], and functional impairment following repetitive/mild traumatic brain injury (MTBI).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02891941
The ClinicalTrials.gov registry entry for NCT02891941 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02891941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02891941 about?
NCT02891941 is a clinical study titled "Neuroimaging & Plasma Markers for Predicting Outcomes After Mild Traumatic Brain Injury". This exploratory study aims to identify the most promising biomarkers that alone or in combination might predict development of mood disorders \[i.e., major depression (MD\], cognitive disorders \[i.e., executive function deficits (EFD)\], and functional impairment following repetitive/mild traumati...
What is the current status of trial NCT02891941?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2013-06. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT02891941?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.